On 7 August 2024, we announced our financial results for the six first months of 2024.

Company announcement

Financial workbook (xlsx)

Investor presentation (iPaper)

Conference call webcast

 

On 8 August 2024, we held a conference call to present our results for the six first months of 2024.

London conference call webcast

Novo Nordisk A/S hosted a R&D investor call in relation to the annual American Heart Association (AHA) conference. This year the conference is hosted in Philadelphia, US.

Presentation (Webcast)
Presentation (pdf)

Novo Nordisk A/S hosted a R&D investor call in relation to the annual ADA conference. This year the conference is hosted in San Diego, CA.

Presentation (Webcast)

Presentation (pdf)

Full-year 2022 financial results were published 01 February 2023, 7:30 CET:


The conference call took place 01 February 2023, 13:00 CET